Abstract: A mobile communication system where a base station and a user equipment communicates on multiple aggregated carriers is disclosed. In the mobile communication system, the base station notifies to the user equipment information which is relevant to inclusion of an information field indicating scheduling carrier in downlink control information format by using radio resource control signaling, and the user equipment receives, from the base station, downlink control information in the downlink control information format according to the information which is relevant to inclusion of the information field indicating scheduling carrier.

Abstract: The present invention is directed to processes for preparing an intermediate for a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved.

Abstract: A liquid crystal display device 10 includes a panel controller 50 and a backlight controller 51. The panel controller 50 drives a liquid crystal panel 11 such that one frame display period includes a red and blue display period and a green display period. In the red and blue display period, red pixels RPX and blue pixels BPX are selectively driven. The backlight controller drives a lighting device to turn on first magenta LEDs 17M1 and the first green LEDs 17G1 until scanning of at least red pixels RPX and blue pixels BPX included in a first area A1 is finished after starting of the scanning, after finishing of the scanning, turn on the first magenta LEDs 17M1 and turn off the first green LEDs 17G1 for at least a certain period until scanning of green pixels BPX included in the first area A1 for a next green display period is started.

Abstract: In a liquid crystal display device (1) according to one aspect of the present invention, each of a first gate driver (17) supplying a gate signal to a first gate line (10) of a first display part (8) and a second gate driver (18) supplying a gate signal to a second gate line (13) of a second display part (9) are constituted to comprise a transistor formed on one surface of an array substrate (2).

Abstract: If a plurality of channel state information reports corresponding to different cells have collided (Yes in step S2408), a mobile station device 1 selects two channel state information reports in accordance with priorities of report types and cell indices of cells, and drops the other channel state information reports (step S2412). The mobile station device 1 transmits the selected two channel state information reports using a resource for PUCCH format 3, which is used in case of collision of a plurality of channel state information reports corresponding to different cells (step S2414).

Abstract: There are provided a terminal device, a base station device, a communication method, an integrated circuit, and a wireless communication system that enable a base station device and a terminal device to determine parameters related to uplink signals or uplink reference signals and to perform efficient communication.

Abstract: The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.

Abstract: The light-emitting section contains a fluorescent substance which is a YAG:Ce fluorescent substance. An average particle size of the fluorescent substance is 1·m or larger and 50·m or smaller, and a sealing material for sealing the fluorescent substance has a density of 2.0 g/cm3 or higher and 7.0 g/cm3 or lower.

Abstract: An EPDCCH is made up of an aggregation of one or more resources obtained by dividing one of PRB pairs. In a case where a total number of antenna ports for transmitting reference signals to be used to demodulate signals mapped to the EPDCCH is four, four resources obtained by dividing one of the PRB pairs correspond to the antenna ports of different numbers. In a case where a total number of antenna ports for transmitting reference signals to be used to demodulate signals mapped to the EPDCCH is two, two resources obtained by dividing one of the PRB pairs correspond to the antenna ports of different numbers. A mobile station apparatus includes a reception processor that demodulates, by using reference signals transmitted from the antenna ports corresponding to the resources used for the EPDCCH, signal mapped to the EPDCCH for which decoding and detection are performed.

Abstract: The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.

Abstract: Thiophene-substituted tetracyclic compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein A, A?, R2, R3, R4 and R5 are as defined herein. The compositions comprising at least one thiophene-substituted tetracyclic compound, and methods of using the thiophene-substituted tetracyclic compounds for treating or preventing HCV infection in a patient are also provided.

Abstract: According to an aspect of the present invention, there is provided a terminal device that communicates with a base station apparatus, the terminal device including: a transmission unit that does not transmit an uplink signal in a secondary cell on the same subframe as a subframe, if the subframe in a primary cell is assumed to be a downlink subframe, in a case where multiple cells that include at least a cell in a first frame structure type (FDD) and a cell in a second frame structure type (TDD) are aggregated, different TDD UL/DL configurations are set in each of the multiple cells in the second frame structure type, and a function of performing transmission and reception at the same time between cells in the second frame structure type for which the different TDD UL/DL configurations are set is not retained.

Abstract: The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

Abstract: The present invention is directed to a process for preparing Tetracyclic Heterocycle Compounds of formula (I): which are useful as HCV NS5A inhibitors. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).

Abstract: A terminal device includes a transmitter that transmits a random access preamble, a higher layer processor that configures, based on a higher layer signal, a first identity corresponding to a first component carrier group and a second identity corresponding to a second component carrier group; a counter that, in a case that two or more component carriers are configured for an uplink, counts a number of transmission of the random access preamble; and a medium access control (MAC) layer processor that indicates a random access problem to an upper layer in a case that the number exceeds a maximum number of transmission of the random access preamble on a master component carrier of the first component carrier group or a master component carrier of the second component carrier group.

Abstract: A display device is provided with an LED; a rectangular liquid crystal panel that uses light from the LED for display; a bezel; and a frame. The bezel forms a rectangular frame following along the outer peripheral edges of the liquid crystal panel, and is configured such that a length thereof in a first direction is variable, or lengths thereof in a first direction and a second direction are variable. The frame forms a rectangular frame following along the outer peripheral edges of the liquid crystal panel, and together with the bezel clamps the outer peripheral edges of the liquid crystal panel.

Abstract: An image forming apparatus includes an image reading unit, an image forming unit, a discharge unit, and a discharge tray. The image reading unit is configured to read a document placed on a document placement table by moving and scanning of a scanning body in a sub-scanning direction. The image forming unit is configured to form an image read by the image reading unit on a paper sheet. The discharge unit is configured to discharge the paper sheet on which an image is formed by the image forming unit to a direction perpendicular to the sub-scanning direction. The discharge tray is on which the paper sheet from the discharge unit is to be placed with a space portion at a lower side of the image reading unit. A bottom surface of a housing of the image reading unit facing the discharge tray is constituted of a first surface and a second surface. The first surface is a surface at a front side of the discharge unit in a discharging direction and high with respect to the discharge tray.

Abstract: LED light source substrates (140) in an edge-light type surface light source device are disposed with a light guide plate interposed therebetween. A length of each of the LED light source substrates is shorter than a length of a plane of incidence of the light guide plate. The chromaticity of light from a central part (141) is uniform, and the chromaticity of light from ends (142) is more shifted toward blue than the chromaticity of light from the central part (141).

Abstract: Provided is an in-cell touch panel having improved display quality. An opposite substrate relating to one embodiment of the present invention is provided with a black matrix, first electrodes, which are disposed in the Y direction, and second electrodes, which are disposed in the X direction. The first electrodes and the second electrodes are formed such that the boundaries therebetween are positioned in regions that coincide with the black matrix in a planar view.

Abstract: The present invention provides compounds of Formula (I): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R1, X, Y, Z, R2, R3, R4, R5, R6, R7, R8, R9, R18, R19 and n is selected independently and as defined herein. Compositions comprising such compounds are also provided. The compounds of the invention are effective as inhibitors of HCV, and are useful, alone and together with other therapeutic agents, in treating or preventing diseases or disorders such as viral infections and virus-related disorders.